Le Lézard
Classified in: Health
Subject: FDA

SEBiotictm Receives No Objections Letter from FDA for GRAS Submission


CHINO, Calif., Feb. 23, 2021 /PRNewswire/ -- Specialty Enzymes & Probiotics is proud to announce SEBiotictm received a No Objections Letter from the FDA for its GRAS, which stands for Generally Recognized As Safe, submission.

The GRAS Notification Program is a voluntary submission for products that are intended as food additives. Based on our extensive research, specifications, intended usage, history, preparation and reports, the GRAS submission for SEBiotictm was reviewed by the FDA and granted a No Further Questions letter regarding its safety.

"We're incredibly proud of the entire team of our scientists, researchers and regulatory staff for this accomplishment," said Vic Rathi, president and CEO of the company.

A shelf-stable and heat-stable probiotic, SEBiotictm, forms a protective endospore that allows it to survive the harsh conditions of the stomach, as well as manufacturing and distribution practices. Due to its shelf-stable and-heat stable properties, it can be stored without refrigeration, saving you valuable money and resources.*

Studies show SEBiotictm promotes microflora balance, supports immunomodulation and intestinal homeostasis, and promotes digestive and abdominal health. The powerful spore-former can be used in dietary supplements, protein powders, drinks and baked goods.

In addition to the FDA letter, SEBiotictm has received approval as a natural health product by Health Canada. It is also Vegan, Kosher, Halal and Non-GMO Project Certified. Learn more at SpecialtyEnzymes.com.

Specialty Enzymes & Probiotics is a leading probiotic manufacturer offering a full line of more than 25 probiotic strains, including Lactobacillus, Saccharomyces, and Bifidobacterium, for a range of nutraceutical, food and beverage applications. We specialize in Bacilli species ? our Bacillus spore-forming probiotic strains are robust and shelf-stable, unrivaled in their ability to withstand harsh environments and remain effective. Plus, they are science-backed with multiple studies showing their safety and benefits.*

As a true manufacturer with decades of experience in nutraceuticals, we have true supply chain visibility and provide unparalleled technical support through every step of the process. Our strict quality standards are backed by a lengthy list of the most rigorous third-party certifications.

Let us help you create your next high quality, natural product!

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

 

SOURCE Speciality Enzymes & Probiotics


These press releases may also interest you

at 20:00
SysInformation Healthcare Services, LLC ("SysInformation"), d/b/a EqualizeRCM and 1st Credentialing, is providing notice of a recent data security event that may affect the security of information related to certain individuals. SysInformation is...

at 19:32
Scottie Resources Corp. ("Scottie" or the "Company") announces that it has granted 7,400,000 options to acquire common shares to certain directors, officers, and consultants to the Company. The options are exercisable at a price of $0.195 per...

at 19:31
DaVita Inc. , announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 2, 2024, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day. This call is...

at 18:05
As part of its ongoing mission to meet the growing need for emergency services in metro Atlanta, Grady Health System will build a freestanding emergency department in south Fulton County. This freestanding emergency department, built in partnership...

at 18:00
Digicann Ventures Ltd. ("Digicann" or the "Company") , a company focused on opportunities within and outside of the cannabis industry, announces that it has entered into an agreement with holders of the Company's 10.00% Senior Unsecured Convertible...

at 18:00
Beauty-Stem, a subsidiary of Power-Stem Biomedical, has been at the forefront of stem cell research and development since its parent company's inception in Taiwan back in 2005. With...



News published on and distributed by: